...
首页> 外文期刊>Drug Design, Development and Therapy >Optimized nano-transfersomal films for enhanced sildenafil citrate transdermal delivery: ex vivo and in vivo evaluation
【24h】

Optimized nano-transfersomal films for enhanced sildenafil citrate transdermal delivery: ex vivo and in vivo evaluation

机译:优化的纳米转运体膜,可增强枸sil酸西地那非的透皮给药:离体和体内评估

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Sildenafil citrate (SLD) is a selective cyclic guanosine monophosphate-specific phosphodiesterase type 5 inhibitor used for the oral treatment of erectile dysfunction and, more recently, for other indications, including pulmonary hypertension. The challenges facing the oral administration of the drug include poor bioavailability and short duration of action that requires frequent administration. Thus, the objective of this work is to formulate optimized SLD nano-transfersomal transdermal films with enhanced and controlled permeation aiming at surmounting the previously mentioned challenges and hence improving the drug bioavailability. SLD nano-transfersomes were prepared using modified lipid hydration technique. Central composite design was applied for the optimization of SLD nano-transfersomes with minimized vesicular size. The independent variables studied were drug-to-phospholipid molar ratio, surfactant hydrophilic lipophilic balance, and hydration medium pH. The optimized SLD nano-transfersomes were developed and evaluated for vesicular size and morphology and then incorporated into hydroxypropyl methyl cellulose transdermal films. The optimized transfersomes were unilamellar and spherical in shape with vesicular size of 130?nm. The optimized SLD nano-transfersomal films exhibited enhanced ex vivo permeation parameters with controlled profile compared to SLD control films. Furthermore, enhanced bioavailability and extended absorption were demonstrated by SLD nano-transfersomal films as reflected by their significantly higher maximum plasma concentration ( C max) and area under the curve and longer time to maxi-mum plasma concentration ( T max) compared to control films. These results highlighted the potentiality of optimized SLD nano-transfersomal films to enhance the transdermal permeation and the bioavailability of the drug with the possible consequence of reducing the dose and administration frequency.
机译:枸den酸西地那非(SLD)是一种选择性的环状鸟苷单磷酸特异性磷酸二酯酶5型抑制剂,用于口服治疗勃起功能障碍,最近用于其他适应症,包括肺动脉高压。口服药物面临的挑战包括生物利用度差和作用时间短,需要经常给药。因此,这项工作的目的是配制具有增强和受控渗透性的优化SLD纳米传递体透皮膜,旨在克服上述挑战,从而提高药物的生物利用度。使用改良的脂质水化技术制备了SLD纳米转移体。中央复合设计被用于优化SLD纳米传递体与最小化的水泡大小。研究的独立变量是药物与磷脂的摩尔比,表面活性剂亲水亲脂平衡和水合介质pH。开发了优化的SLD纳米转移体并评估了囊泡的大小和形态,然后将其掺入羟丙基甲基纤维素透皮薄膜中。优化的传递体为单层和球形,囊泡大小为130?nm。与SLD对照膜相比,优化的SLD纳米传递体膜表现出增强的离体渗透参数,并且具有可控的轮廓。此外,SLD纳米传递体膜显示出更高的生物利用度和扩展的吸收能力,这表现为它们的最高血浆浓度(C max )和曲线下面积显着较高,并且达到最高血浆浓度所需的时间更长( T max )。这些结果凸显了优化的SLD纳米传递体膜具有增强药物的透皮渗透和生物利用度的潜力,并可能降低剂量和给药频率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号